Rapid cGMP manufacturing of COVID-19 monoclonal antibody using stable CHO cell pools안정적인 CHO 세포 풀을 사용하여 COVID-19 단일 클론 항체의 신속한 cGMP 제조Article Published on 2022-02-012022-09-11 Journal: Biotechnology and bioengineering [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] accelerated activities acute respiratory syndrome acute respiratory syndrome coronavirus approach Cell cell bank Cell culture cGMP cGMP manufacturing CHO cell CHO pools clinical trial clone comparability coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 Critical demonstrated Final generate host cell material monoclonal antibodies monoclonal antibody monoclonal antibody. pandemic performed Phase 1 Phase 1 clinical trial Proteins provided Rapid respiratory subsequent supply Testing timeline transposase [DOI] 10.1002/bit.27995 PMC 바로가기 [Article Type] Article